NovaBay Pharmaceuticals, Inc. (NBY)
USD 0.49
(-9.24%)
USD 0.49
(-9.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.31 Million | -6.65 Million | -9.19 Million | -4.72 Million | -7.92 Million | -5.56 Million |
| Net Income | -9.64 Million | -10.6 Million | -5.82 Million | -11.03 Million | -9.65 Million | -6.54 Million |
| Depreciation & Amortization | 203 Thousand | 483 Thousand | 119 Thousand | 51 Thousand | 65 Thousand | 266 Thousand |
| Deferred income taxes | -616 Thousand | - | - | 5.26 Million | -849 Thousand | - |
| Stock-based compensation | 291 Thousand | 220 Thousand | 1.15 Million | 701 Thousand | 621 Thousand | 594 Thousand |
| Change in working capital | 750 Thousand | 533 Thousand | -38 Thousand | 210 Thousand | 1.2 Million | 1.35 Million |
| Other non-cash items | 4.7 Million | 2.71 Million | -4.61 Million | 89 Thousand | 688 Thousand | -1.23 Million |
| Investing Cash Flow | -19 Thousand | -112 Thousand | -12.04 Million | -26 Thousand | -19 Thousand | -44 Thousand |
| Investments in PPE | -19 Thousand | -112 Thousand | -52 Thousand | -26 Thousand | -19 Thousand | -44 Thousand |
| Acquisitions | - | - | -11.99 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -11.99 Million | - | - | - |
| Financing Cash Flow | 2.09 Million | 4.63 Million | 16.78 Million | 9.76 Million | 11.7 Million | 5.59 Million |
| Debt repayment | -1.47 Million | -105 Thousand | -105 Thousand | -2.56 Million | -652 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.56 Million | 4.73 Million | 16.68 Million | 5.22 Million | 6.69 Million | 5.58 Million |
| Other Financing Activities | -181 Thousand | 4.63 Million | 16.78 Million | 7.1 Million | 5.65 Million | 12 Thousand |
| Accounts receivables | 1.21 Million | -305 Thousand | 452 Thousand | -317 Thousand | 2.31 Million | 774 Thousand |
| Accounts payables | -1.15 Million | 667 Thousand | -163 Thousand | 321 Thousand | -862 Thousand | 516 Thousand |
| Inventory | 560 Thousand | -217 Thousand | -243 Thousand | -116 Thousand | -212 Thousand | 198 Thousand |
| Other working capital | 134 Thousand | 388 Thousand | -84 Thousand | 322 Thousand | -41 Thousand | -138 Thousand |
| Cash at beginning of period | 5.36 Million | 7.97 Million | 12.42 Million | 7.41 Million | 3.65 Million | 3.67 Million |
| Cash at end of period | 3.13 Million | 5.84 Million | 7.97 Million | 12.42 Million | 7.41 Million | 3.65 Million |
| Capital Expenditure | -19 Thousand | -112 Thousand | -52 Thousand | -26 Thousand | -19 Thousand | -44 Thousand |
| Effect of forex changes on cash | 8000.00 | - | - | - | - | - |
| Net cash flow / Change in cash | -2.23 Million | -2.13 Million | -4.44 Million | 5.01 Million | 3.75 Million | -15 Thousand |
| Free Cash Flow | -4.33 Million | -6.76 Million | -9.24 Million | -4.74 Million | -7.94 Million | -5.61 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.58 Million | -3.09 Million | -9.64 Million | -4.1 Million | -1.75 Million | -2.03 Million |
| Depreciation & Amortization | 11 Thousand | 12 Thousand | 203 Thousand | 50 Thousand | 51 Thousand | 51 Thousand |
| Deferred income taxes | - | - | -616 Thousand | 531 Thousand | -285 Thousand | - |
| Stock-based compensation | 55 Thousand | 60 Thousand | 291 Thousand | 90 Thousand | 62 Thousand | 64 Thousand |
| Change in working capital | 230 Thousand | 57 Thousand | 750 Thousand | 537 Thousand | 619 Thousand | -408 Thousand |
| Other non-cash items | 393 Thousand | 1.3 Million | 4.7 Million | 2.69 Million | 947 Thousand | 486 Thousand |
| Investing Cash Flow | -2000.00 | 1.06 Million | -19 Thousand | -2000.00 | -2000.00 | -2000.00 |
| Investments in PPE | -2000.00 | -2000.00 | -19 Thousand | -2000.00 | -2000.00 | -2000.00 |
| Acquisitions | - | 1.07 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 1.07 Million | - | - | - | - |
| Financing Cash Flow | -396 Thousand | -578 Thousand | 2.09 Million | -139 Thousand | -577 Thousand | 2.51 Million |
| Debt repayment | -622 Thousand | -578 Thousand | -1.47 Million | -3.7 Million | -577 Thousand | -193 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 226 Thousand | - | 3.56 Million | 3.56 Million | - | - |
| Other Financing Activities | -96 Thousand | -19 Thousand | -181 Thousand | 113 Thousand | -577 Thousand | 2.7 Million |
| Accounts receivables | 187 Thousand | -54 Thousand | 1.21 Million | 157 Thousand | 1.7 Million | -788 Thousand |
| Accounts payables | 149 Thousand | 308 Thousand | -1.15 Million | -170 Thousand | -1.42 Million | 279 Thousand |
| Inventory | -37 Thousand | -107 Thousand | 560 Thousand | 616 Thousand | 167 Thousand | 137 Thousand |
| Other working capital | -69 Thousand | -90 Thousand | 134 Thousand | -66 Thousand | 165 Thousand | -36 Thousand |
| Cash at beginning of period | 1.82 Million | 3.13 Million | 5.36 Million | 3.47 Million | 4.89 Million | 4.22 Million |
| Cash at end of period | 751 Thousand | 1.82 Million | 3.13 Million | 3.13 Million | 3.94 Million | 4.89 Million |
| Capital Expenditure | -2000.00 | -2000.00 | -19 Thousand | -2000.00 | -2000.00 | -2000.00 |
| Effect of forex changes on cash | - | - | 8000.00 | - | - | - |
| Net cash flow / Change in cash | -1.07 Million | -1.3 Million | -2.23 Million | -342 Thousand | -942 Thousand | 668 Thousand |
| Free Cash Flow | -676 Thousand | -1.59 Million | -4.33 Million | -203 Thousand | -365 Thousand | -1.84 Million |
SNWV
5238
6550
AKMYF
ACWRF
7214